Federal Supply Schedule 36F79725D0234

Award Date 9/29/25
Last Date to Order 9/28/30
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This federal contract Indefinite Delivery Vehicle (IDV) is a multiple-award Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) awarded by the U.S. Department of Veterans Affairs (VA) to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc. The $3.1 billion contract has an ultimate completion date of August 31, 2029 and enables VA buying offices to efficiently procure critical oncology and specialty medications to support comprehensive healthcare...
This federal contract Indefinite Delivery Vehicle (IDV) is a single-award Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc. The BPA has a ceiling value of $15,000,000 and a period of performance through September 19, 2026. The purpose of this BPA is to provide the VA with the oncology medications BALVERSA and CARVYKTI. This IDV is issued against the Pharmaceuticals...
The Department of Veterans Affairs (VA) awarded a multiple-award Federal Supply Schedule (FSS-61-IB) contract to Janssen Products LP, a subsidiary of Johnson & Johnson, with a total potential value of $881 million through 2025. This contract vehicle allows the VA's regional Veterans Integrated Service Networks (VISNs) to place delivery orders for pharmaceutical products, particularly the antitubercular medication Sirturo (bedaquiline) and the oncology drug Balversa (erdafitinib). The VA...
The federal contract IDV award is a multiple award blanket purchase agreement between the Department of Veterans Affairs Veterans Health Administration and Janssen Biotech, Inc. The BPA utilizes Janssen's Pharmaceuticals and Drugs Federal Supply Schedule, referred to as FSS-61-IB, to provide for the delivery of Balversa and Belzutifan medications to various Veterans Integrated Service Networks. Delivery locations under the BPA include Carrollton, Texas; Chelsea, Maine; and Horsham,...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA). The prime contractor is Amphastar Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical goods. The $58,244,500 multiple award contract has a period of performance through January 14, 2027 and aims to procure a broad range of drug,...
The federal contract IDV award is a Federal Supply Schedule contract with the Department of Veterans Affairs to provide pharmaceutical and hematology-related products. The 5-year, $250,000 multiple award IDV enables VA medical centers in Veterans Integrated Service Network 12 to procure hematology products without separate solicitations. The prime contractor is 60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company that develops and commercializes infectious disease medicines. 60...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products. The contracting agency is the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 12 (VISN 12). The prime contractor is Reata Pharmaceuticals, Inc., a for-profit organization. The contract has a ceiling value of $25,000.00 and a period of performance ending on October 23, 2023. It is a multiple...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products. The contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The prime contractor is Usantibiotics LLC, a for-profit organization. The contract is an interim agreement with a ceiling value of $25,000.00 and a period of performance through April 1, 2023. The contract does...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract for the procurement of drugs, pharmaceuticals, and hematology-related products. The contract was awarded to Perrigo Company, a foreign-owned, for-profit manufacturer of goods, on October 1, 2018, with a ceiling value of $506,112,050.00 and a period of performance through September 30, 2026. The contract is a multiple-award, non-set-aside FSS contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule. The...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 IB, which covers Drugs, Pharmaceuticals, and Hematology Related Products. The contract was awarded to HLS Therapeutics Inc., a for-profit manufacturer, on July 1, 2022 by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract has a ceiling value of $13,848,500.00 and a period of performance through June 30, 2027. It is a multiple award...
  • 36F79725D0234
    Federal Supply Schedule
  • -
    Blanket Purchase Agreements

The federal contract IDV award is a multiple-award Federal Supply Schedule (FSS-61-IB) contract for pharmaceutical products, awarded by the Department of Veterans Affairs (VA) to Janssen Products, LP, doing business as Ortho Biotech Products, LP. The contract has a ceiling value of $468 million and a period of performance through September 2030.

Under this IDV, Janssen Products, LP provides a range of pharmaceutical products, including the antitubercular medication Sirturo (bedaquiline) and the oncology drug Balversa (erdafitinib), to various VA regional networks known as Veterans Integrated Service Networks (VISNs). The company operates as the prime contractor, with no major subcontractors or set-aside designations mentioned. Task orders under this IDV are primarily awarded by the different VA VISNs, supporting the agency's mission to provide comprehensive healthcare services to veterans, including the treatment of infectious diseases and cancer.

Generated 9/10/25, 9:56 AM